| Stem definition | Drug id | CAS RN |
|---|---|---|
| hypoxia inducible factor (HIF) prolyl hydroxylase inhibitors | 5420 | 1000025-07-9 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| April 24, 2023 | EMA | AKEBIA EUROPE LIMITED | |
| June 29, 2020 | PMDA | Mitsubishi Tanabe Pharma |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | B03XA08 | BLOOD AND BLOOD FORMING ORGANS ANTIANEMIC PREPARATIONS OTHER ANTIANEMIC PREPARATIONS Other antianemic preparations |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Anemia of renal disease | indication | 234348004 | |
| Anemia in chronic kidney disease | indication | 707323002 |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Egl nine homolog 1 | Enzyme | INHIBITOR | IC50 | 7.81 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
| Egl nine homolog 2 | Enzyme | INHIBITOR | IC50 | 7.93 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
| Egl nine homolog 3 | Enzyme | INHIBITOR | IC50 | 8.12 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
| Vascular endothelial growth factor A | Secreted | EC50 | 5.12 | CHEMBL | |||||
| Hypoxia-inducible factor 1-alpha inhibitor | Enzyme | IC50 | 4.54 | CHEMBL | |||||
| Prolyl 3-hydroxylase OGFOD1 | Unclassified | IC50 | 5.85 | CHEMBL | |||||
| Prolyl 4-hydroxylase | Unclassified | Ki | 6.55 | CHEMBL |
| ID | Source |
|---|---|
| D11078 | KEGG_DRUG |
| I60W9520VV | UNII |
| C4519730 | UMLSCUI |
| A1Z | PDB_CHEM_ID |
| CHEMBL3646221 | ChEMBL_ID |
| 23634441 | PUBCHEM_CID |
| DB12255 | DRUGBANK_ID |
| 11831 | IUPHAR_LIGAND_ID |
| C000624313 | MESH_SUPPLEMENTAL_RECORD_UI |
| 10289 | INN_ID |
None